Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Current Medicinal Chemistry|December 8, 2004
Potassium channel blockade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other autoimmune diseasesRaymond S Norton, Michael W Pennington, Heike Wulff
Inflammation & Allergy Drug Targets|August 10, 2011
Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseasesChristine Beeton, Michael W Pennington, Raymond S Norton
Bioorganic & Medicinal Chemistry|October 10, 2017
Peptide therapeutics from venom: Current status and potentialMichael W Pennington, Andrzej Czerwinski, Raymond S Norton
The Journal of Organic Chemistry|June 19, 2004
Efficient asymmetric synthesis of (S)- and (R)-N-Fmoc-S-trityl-alpha-methylcysteine using camphorsultam as a chiral auxiliarySatendra Singh, Samala J Rao, Michael W Pennington
Expert Opinion on Therapeutic Targets|June 23, 2009
Kv1.3 potassium channels as a therapeutic target in multiple sclerosisSrikant Rangaraju, Victor Chi, Michael W Pennington, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 7, 2007
Targeted tyrosine iodination in a multi-tyrosine vasopressin analogJacques A Durr, Mary Blankenship, Satendra S Chauhan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2017
KCa1.1 channels regulate β1-integrin function and cell adhesion in rheumatoid arthritis fibroblast-like synoviocytesMark R Tanner, Michael W Pennington, Teresina Laragione, et al.
The Journal of Biological Chemistry|June 10, 2017
Reinvestigation of the biological activity of d-allo-ShK proteinBobo Dang, Sandeep Chhabra, Michael W Pennington, et al.
Angewandte Chemie (International Ed. in English)|March 8, 2014
Total synthesis of human hepcidin through regioselective disulfide-bond formation by using the safety-catch cysteine protecting group 4,4'-dimethylsulfinylbenzhydrylZoltan Dekan, Mehdi Mobli, Michael W Pennington, et al.
Biochemistry|October 3, 2002
Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, Kv1.3Mark D Lanigan, Katalin Kalman, Yann Lefievre, et al.
Pageof 6